Lutein + zeaxanthin

Lutein + zeaxanthin has been studied in 38 papers since 2016: 5 trials and 24 observational studies in people, 7 reviews; 8 in the past year. Its furthest trials in people are at phase 3. The newest paper, Oct 26, 2026: “Associations Between Dietary Carotenoids and Cognitive Performance in Older Hispanic/Latino Adults are Stronger in Men and Smokers”.

InterventionPhase 3

38 papers study it104 more mention it39 findingsUpdated

PubChemPubChemChEBIChEBI

2 new papers in 30 daysSee all 142 papers on lutein + zeaxanthin

At a glance

Independent labs found the same change in people. 14 independent labs in 4 countries; 5 trials, none about aging, 3 with no results posted.

“and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.”
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28JAMA ophthalmology2022doi:10.1001/jamaophthalmol.2022.1640

2 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 14 independent labs in 4 countries
  • 2 findings against
  • 5 trials, none about aging, 3 with no results posted
  • Funders: National Institutes of Health and others
  • 9 of 34 findings with company ties
  • Human trial5
  • Humans24
  • In silico1

Studies in people

4 studies gave lutein + zeaxanthin to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on lung cancerOR 1.15 (95% CI, 0.79-1.66)

down: Lowers the risk of age-related macular degenerationHR 0.91 (95% CI, 0.84-0.99)

Treated cohort10 years3,882 peopleBoth72.0 yearsOlder adults; 10-year follow-upJAMA ophthalmology, Jun 3, 2022

up: Improves contrast sensitivity with glare0.147 and 0.149 LogMAR (p = 0.02 and 0.01)

down: Decreases glare recovery time2.76 and 2.54 s (p = 0.008 and p = 0.02)

up: Improves useful field of view divided attentionp < 0.001

Randomized trialsix-month24 peopleBothelderlyOlder adultsNutrients, Sep 14, 2021

down: Decreases gray matter volume decline

Randomized trial12 monthsBoth65-87 yearsOlder adults; in supplement responders with greater increases in MPOD, exploratory analysisJournal of aging research, Dec 1, 2019

up: Increases blood-oxygen-level dependent signal

no change: Has no effect on cognitive functiond=.84

up: Increases macular pigment optical density

Randomized trial1 year44 people64–86 years of ageCommunity-dwelling older adultsJournal of the International Neuropsychological Society : JINS, Jul 11, 2017

What did studies of lutein + zeaxanthin find?

17

Studies of lutein + zeaxanthin measured 17 outcomes; the most studied are macular pigment optical density (4 studies) and cognitive function (2).

Macular pigment optical density

upin humans3no changein humans1

4 studies
  1. Lutein + zeaxanthin showed no clear effect on macular pigment optical density in humans (healthy participants).

    “while no changes were noted in the LZ group.”

    Human trialhealthy participantssupplementmacula6 mg lutein and 4 mg zeaxanthin, five times weekly90 days

    Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial

    Nutrients

  2. Lutein + zeaxanthin increases macular pigment optical density in humans.

    “The supplement group’s MPOD was significantly greater than the control group’s MPOD following the intervention [t(42)=2.44; p=.019], despite the two groups showing comparable MPOD at baseline (p >.05).”

    Human trial1 yearn = 44

    Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial

    Journal of the International Neuropsychological Society : JINS

  3. Lutein + zeaxanthin increases macular pigment optical density in humans.

    “Supplementation with lutein 10 mg and zeaxanthin 2 mg in AREDS 2 has been proven to increase MPOD”

    ReviewAREDS 2 formulationmaculalutein 10 mg and zeaxanthin 2 mg

    The Role of Lutein and Zeaxanthin in the AREDS 2 Formulation: Protective Mechanisms and Clinical Implementation in Age-Related Macular Degeneration

    Cermin Dunia Kedokteran

  4. Lutein + zeaxanthin increases macular pigment optical density in humans (populations with and without age-related macular degeneration) (Significant increases in 2 of 8 controlled studies).

    “MPOD increased significantly in 2 of the 8 controlled studies.”

    Reviewpopulations with and without age-related macular degenerationdietary interventionmacula

    An appraisal of trials investigating the effects on macular pigment optical density of lutein and zeaxanthin dietary interventions: a narrative review

    Nutrition reviews

More on Macular pigment optical density

Cognitive function

upin humans2no changein humans1+12%

2 studies
  1. Lutein + zeaxanthin showed no clear effect on cognitive function in humans (d=.84).

    “A mixed design ANOVA did not yield a statistically significant group (supplement vs. placebo) × time (baseline vs. post-intervention) interaction for number of words recalled within the scanner [F(1,42)=2.53; p=.119], although the effect size was large (d=.84).”

    Human trial1 yearn = 44

    Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial

    Journal of the International Neuropsychological Society : JINS

  2. Lutein + zeaxanthin improves cognitive function in humans (community-dwelling) (Cohen's d=.84).

    “L and Z appeared to buffer cognitive decline on the verbal learning task (Cohen's d=.84).”

    Human trialcommunity-dwelling12 mg/daily1 yearn = 44

    Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial

    Journal of the International Neuropsychological Society : JINS

  3. Lutein + zeaxanthin improves cognitive function in humans (up to 12%).

    “while in older adults, it boosts cognitive function by up to 12%.”

    Review

    LUTEIN AND ZEAXANTHIN IN THE PREVENTION AND TREATMENT OF AGE-RELATED EYE DISEASES: A REVIEW OF EFFICACY AND BIOAVAILABILITY STUDIES WITH A FOCUS ON OCULAR AND COGNITIVE HEALTH

    International Journal of Innovative Technologies in Social Science

Blood-oxygen-level dependent signal

upin humans1

1 study
  1. Lutein + zeaxanthin increases blood-oxygen-level dependent signal in humans.

    “Following the encoding minus control contrast, significant group (supplement vs. placebo) × time (baseline vs. post-intervention) interactions were observed in left dorsolateral prefrontal cortex (F=21.34; p=.034, FWE-corrected, cluster size: 498 voxels) and anterior cingulate cortex (F=19.63; p=.028, FWE-corrected, cluster size: 146 voxels; see Figure 3”

    Human trial1 yearn = 44

    Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial

    Journal of the International Neuropsychological Society : JINS

  2. Lutein + zeaxanthin increases blood-oxygen-level dependent signal in humans (community-dwelling) (p < .05).

    “Significant interactions during learning were observed in left dorsolateral prefrontal cortex and anterior cingulate cortex (p < .05, family-wise-error corrected).”

    Human trialcommunity-dwellingprefrontal cortex12 mg/daily1 yearn = 44

    Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial

    Journal of the International Neuropsychological Society : JINS

More on Blood-oxygen-level dependent signal

Cognitive decline

downin humans1

1 study
  1. Lutein + zeaxanthin is linked with less cognitive decline in humans (β = 0.020, 95% CI: 0.002-0.037).

    “lutein + zeaxanthin (β = 0.020, 95% CI: 0.002-0.037)”

    Humansn = 4,043

    Dietary Carotenoids and Cognitive Decline: A Longitudinal Study Among Chinese Middle-Aged and Older Adults

    Health care science

Coronary artery disease

downin humans1

1 study
  1. Lutein + zeaxanthin is linked with less coronary artery disease in humans with accelerated aging.

    “Both SHAP and LIME analyses consistently identified vitamin B12 and lutein + zeaxanthin as protective nutrients”

    Humanswith accelerated aging

    Interpretable prediction of coronary heart disease risk in adults over 50 with accelerated aging using 45 dietary nutrients

    Frontiers in nutrition

More on Coronary artery disease

Biological aging

downin humans1OR 0.93

1 study
  1. Lutein + zeaxanthin is linked with lower biological aging in humans (OR 0.93, 95% CI 0.88–0.93, P = 0.016).

    “Combined LZ intake is associated with attenuated multi-level biological aging [OR (95% CI): 0.93 (0.88, 0.93), P = 0.016]”

    Humans

    The association between lutein and zeaxanthin intake and multi-level biological aging

    Frontiers in nutrition

More on Biological aging

Age-related macular degeneration

downin humans1

1 study
  1. Lutein + zeaxanthin protects against age-related macular degeneration in humans.

    “leads to eye's protective functions of them including protection from age-related macular degeneration (AMD).”

    Reviewmacula

    Lutein and zeaxanthin - radio- and chemoprotective properties. Mechanism and possible use

    Roczniki Panstwowego Zakladu Higieny

More on Age-related macular degeneration

HDL cholesterol

upin humans1

1 study
  1. Lutein + zeaxanthin increases HDL cholesterol in humans (WMD: 4.06; 95% CI: 0.64, 7.48).

    “L/Z treatment could significantly increase HDL-C levels in older adults (WMD: 4.06; 95% CI: 0.64, 7.48; I-square: 50.7%)”

    Review

    The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study

    Prostaglandins & other lipid mediators

More on HDL cholesterol

LDL cholesterol

no changein humans1

1 study
  1. Lutein + zeaxanthin showed no clear effect on LDL cholesterol in humans (WMD: -4.54; 95% CI: -11.5, 2.48).

    “L/Z supplementation has null effect on circulating levels of TC (WMD: -3.82 95% CI: -13.83, 6.18; I-square: 85.2%), and LDL-C (WMD: -4.54; 95% CI: -11.5, 2.48; I-square: 83.9%)”

    Review

    The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study

    Prostaglandins & other lipid mediators

More on LDL cholesterol

Total cholesterol

no changein humans1

1 study
  1. Lutein + zeaxanthin showed no clear effect on total cholesterol in humans (WMD: -3.82 95% CI: -13.83, 6.18).

    “L/Z supplementation has null effect on circulating levels of TC (WMD: -3.82 95% CI: -13.83, 6.18; I-square: 85.2%)”

    Review

    The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study

    Prostaglandins & other lipid mediators

More on Total cholesterol

Lung cancer

no changein humans1OR 1.15

1 study
  1. Lutein + zeaxanthin showed no clear effect on lung cancer in humans (10-year follow-up) (OR 1.15 (95% CI, 0.79-1.66)).

    “and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.”

    Human trial10-year follow-up10 yearsn = 3,882

    Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

    JAMA ophthalmology

More on Lung cancer

Skin carotenoids

no changein humans1

1 study
  1. Lutein + zeaxanthin showed no clear effect on skin carotenoids in humans (healthy participants).

    “Skin carotenoids were significantly increased in the goji berry group at day 45 (p = 0.025) and day 90 (p = 0.006), but not in the LZ group.”

    Human trialhealthy participantssupplementskin6 mg lutein and 4 mg zeaxanthin, five times weekly45 and 90 days

    Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial

    Nutrients

More on Skin carotenoids

Composite crash risk score

downin humans1

1 study
  1. Lutein + zeaxanthin decreases composite crash risk score in humans (p = 0.004).

    “improved composite crash risk score (p = 0.004) were seen in the supplemented group.”

    Human trialsix-monthn = 24

    Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults

    Nutrients

More on Composite crash risk score

Useful field of view divided attention

upin humans1

1 study
  1. Lutein + zeaxanthin improves useful field of view divided attention in humans (p < 0.001).

    “Improvements in UFOV scores of divided attention (p < 0.001) and improved composite crash risk score (p = 0.004) were seen in the supplemented group.”

    Human trialsix-monthn = 24

    Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults

    Nutrients

Glare recovery time

downin humans1

1 study
  1. Lutein + zeaxanthin decreases glare recovery time in humans (2.76 and 2.54 s (p = 0.008 and p = 0.02)).

    “monocularly tested glare recovery time improved 2.76 and 2.54 s, respectively, (p = 0.008 and p = 0.02)”

    Human trialeyesix-monthn = 24

    Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults

    Nutrients

All 17

What is lutein + zeaxanthin linked with?

12

Studies link lutein + zeaxanthin with 12 measures, most often age-related macular degeneration (5 studies).

Age-related macular degeneration

downin humans5HR 0.91

5 studies
  1. Lutein + zeaxanthin lowers the risk of age-related macular degeneration in humans (comparing lutein/zeaxanthin with no lutein/zeaxanthin) (HR 0.91 (95% CI, 0.84-0.99)).

    “The hazard ratio (HR) for progression to late AMD comparing lutein/zeaxanthin with no lutein/zeaxanthin was 0.91 (95% CI, 0.84-0.99; P = .02)”

    Human trialcomparing lutein/zeaxanthin with no lutein/zeaxanthin10 yearsn = 3,882

    Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

    JAMA ophthalmology

  2. Lutein + zeaxanthin is linked with a lower risk of age-related macular degeneration in individuals with P. gingivalis-related AMD risk (by as much as 35% (P for interaction < 0.0001)).

    “sustaining elevated serum levels of lutein/zeaxanthin (≥ 0.35 μmol/L or ≥ 20 μg/dL) might potentially mitigate the P. gingivalis-related AMD risk by as much as 35%”

    Humansin individuals with P. gingivalis-related AMD risk≥ 0.35 μmol/L or ≥ 20 μg/dL

    Interaction between serum levels of Porphyromonas gingivalis immunoglobulin G and lutein/zeaxanthin is associated with risk for age-related macular degeneration

    Scientific reports

  3. Lutein + zeaxanthin is linked with a lower risk of age-related macular degeneration in humans (comparing the top and bottom tertiles) (OR 0.21, 95% CI 0.05-0.84).

    “higher lutein/zeaxanthin content in plasma was significantly associated with a decreased risk of AMD, and the odds ratio (OR) comparing the top and bottom tertiles was 0.21 (95% CI: 0.05, 0.84”

    Humanscomparing the top and bottom tertiles

    The Associations of Plasma Carotenoids and Vitamins With Risk of Age-Related Macular Degeneration: Results From a Matched Case-Control Study in China and Meta-Analysis

    Frontiers in nutrition

  4. Lutein + zeaxanthin lowers the risk of age-related macular degeneration in humans (18–26%).

    “Supplementation reduces the risk of AMD progression by 18–26%”

    Review

    LUTEIN AND ZEAXANTHIN IN THE PREVENTION AND TREATMENT OF AGE-RELATED EYE DISEASES: A REVIEW OF EFFICACY AND BIOAVAILABILITY STUDIES WITH A FOCUS ON OCULAR AND COGNITIVE HEALTH

    International Journal of Innovative Technologies in Social Science

  5. Lutein + zeaxanthin lowers the risk of age-related macular degeneration in older adults.

    “high concentration of carotenoids such as lutein and zeaxanthin decrease the risk of developing age-related macular disease”

    Reviewin older adults

    Review of Evidence for the Usage of Antioxidants for Eye Aging

    BioMed research international

More on Age-related macular degeneration

Cognitive function

upin humans1

1 study
  1. Lutein + zeaxanthin is associated with cognitive function in humans (Hispanic/Latino adults) (β=0.21; p≤0.04).

    “total carotenoids (β=0.26), α-carotene (β=0.22), β-cryptoxanthin (β=1.0), lutein+zeaxanthin (β=0.21), and lycopene (β=0.19) were significantly (all ps ≤ 0.04) associated with cognitive performance.”

    HumansHispanic/Latino adults

    Associations Between Dietary Carotenoids and Cognitive Performance in Older Hispanic/Latino Adults are Stronger in Men and Smokers

    The Journal of nutrition

Cataract

downin humans1

1 study
  1. Lutein + zeaxanthin lowers the risk of cataract in humans (20–25%).

    “cortical cataracts by 20–25%”

    Review

    LUTEIN AND ZEAXANTHIN IN THE PREVENTION AND TREATMENT OF AGE-RELATED EYE DISEASES: A REVIEW OF EFFICACY AND BIOAVAILABILITY STUDIES WITH A FOCUS ON OCULAR AND COGNITIVE HEALTH

    International Journal of Innovative Technologies in Social Science

More on Cataract

Macular pigment optical volume

upin humans1

1 study
  1. Lutein + zeaxanthin is associated with macular pigment optical volume in humans (3-mm-diameter macula lutea in eAMD and iAMD) (r = 0.22-0.30, P < 0.01).

    “weaker but significant for L&Z intake, and MPOV (r = 0.22-0.30, P < 0.01) of 3-mm-diameter macula lutea only, for eAMD and iAMD.”

    Humans3-mm-diameter macula lutea in eAMD and iAMDretinan = 369

    Xanthophyll Carotenoid Intake, Plasma Levels, and Retinal Visualization in Aging and Age-Related Macular Degeneration: ALSTAR2

    Investigative ophthalmology & visual science

More on Macular pigment optical volume

Plasma lutein and zeaxanthin

upin humans1

1 study
  1. Lutein + zeaxanthin is associated with plasma lutein and zeaxanthin in humans (total intake from diet and supplements) (Spearman r = 0.29-0.50, P < 0.01).

    “moderate between total intake and plasma L&Z (Spearman r = 0.29-0.50, P < 0.01)”

    Humanstotal intake from diet and supplementsplasman = 369

    Xanthophyll Carotenoid Intake, Plasma Levels, and Retinal Visualization in Aging and Age-Related Macular Degeneration: ALSTAR2

    Investigative ophthalmology & visual science

More on Plasma lutein and zeaxanthin

Age-related macular degeneration progression

downin humans1

1 study
  1. Lutein + zeaxanthin lowers the risk of age-related macular degeneration progression in humans (age-related macular degeneration) (10%–26% reduction in progression risk).

    “reduce the risk of progression of age-related macular degeneration (AMD) by 10%–26%.”

    Reviewage-related macular degenerationAREDS 2 formulationmaculalutein 10 mg and zeaxanthin 2 mg

    The Role of Lutein and Zeaxanthin in the AREDS 2 Formulation: Protective Mechanisms and Clinical Implementation in Age-Related Macular Degeneration

    Cermin Dunia Kedokteran

More on Age-related macular degeneration progression

Mortality

downin humans1

1 study
  1. Lutein + zeaxanthin is linked with a lower risk of mortality in humans (P < 0.001).

    “high LZ intake significantly reduce the risk of all-cause death (P < 0.001)”

    Humans

    The association between lutein and zeaxanthin intake and multi-level biological aging

    Frontiers in nutrition

Soluble Klotho

upin humans1

1 study
  1. Lutein + zeaxanthin is associated with soluble Klotho in humans.

    “increased intake of α-carotene, β-carotene, and lutein with zeaxanthin was associated with elevated S-Klotho levels”

    Humans

    Aging and antioxidants: the impact of dietary carotenoid intakes on soluble klotho levels in aged adults

    Frontiers in endocrinology

More on Soluble Klotho

Osteoporosis

downin humans1OR 0.53

1 study
  1. Lutein + zeaxanthin is linked with a lower risk of osteoporosis in humans (OR 0.53, 95% CI 0.30–0.94; quintile 5 versus 1; P for trend = 0.076).

    “A very high intake of lutein + zeaxanthin was also associated with lower risk of osteoporosis.”

    Humansquintile 5 versus quintile 1both; 57.5% females

    Dietary carotenoid intake and osteoporosis: the National Health and Nutrition Examination Survey, 2005-2018

    Archives of osteoporosis

More on Osteoporosis

Retinal venule caliber

upin humans1

1 study
  1. Lutein + zeaxanthin is associated with retinal venule caliber in humans (214.6 ± 2.2 μm vs. 207.5 ± 2.2 μm).

    “higher serum L/Z (tertile 3 vs. 1) was positively associated with arteriole caliber (mean ± SE, 145.0 ± 1.4 μm vs. 140.8 ± 1.4 μm; P = 0.05) and venule caliber (214.6 ± 2.2 μm vs. 207.5 ± 2.2 μm; P = 0.03).”

    Humansretinafemalesn = 390

    Serum and Macular Carotenoids in Relation to Retinal Vessel Caliber Fifteen Years Later, in the Second Carotenoids in Age-Related Eye Disease Study

    Investigative ophthalmology & visual science

All 12

Has lutein + zeaxanthin been tested in people?

0 of 5 about aging

Yes: 5 trials and 24 observational studies in people have been published, and 5 trials are registered.

In trials

All 8

Stopped

  • NCT00596024TerminatedAlzheimer's disease

    Lack of enrollment

Trial sponsors

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 2Mar 2026: 1Apr 2026: 7May 2026: 1Jun 2026: 0Jul 2026: 5Aug 2026: 2Sep 2026: 3Oct 2026: 2Nov 2026: 026 papers in 12 months

See all 142 papers on lutein + zeaxanthin